Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylviane de Viron

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Open|October 17, 2025
Regional variation in clinical-trial risks: a large-scale analysis of 585 clinical trialsSylviane de Viron, Steve Young, Laura Trotta, et al.
Therapeutic Innovation & Regulatory Science|June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical DevelopmentAbigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science|February 9, 2024
Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical TrialsSylviane de Viron, Laura Trotta, William Steijn, et al.
Therapeutic Innovation & Regulatory Science|October 21, 2022
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator OutcomesSylviane de Viron, Laura Trotta, William Steijn, et al.
Journal of Medical Internet Research|September 11, 2013
Communicating genetics and smoking through social media: are we there yet?Sylviane de Viron, L Suzanne Suggs, Angela Brand, et al.
BMC Medical Genetics|July 26, 2014
Genetic similarities between tobacco use disorder and related comorbidities: an exploratory studySylviane de Viron, Servaas A Morré, Herman Van Oyen, et al.
Plos One|July 19, 2012
Impact of genetic notification on smoking cessation: systematic review and pooled-analysisSylviane de Viron, Johan Van der Heyden, Elena Ambrosino, et al.
Therapeutic Innovation & Regulatory Science|September 30, 2021
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical MonitoringSylviane de Viron, Laura Trotta, Helmut Schumacher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Open|October 17, 2025
Regional variation in clinical-trial risks: a large-scale analysis of 585 clinical trialsSylviane de Viron, Steve Young, Laura Trotta, et al.
Therapeutic Innovation & Regulatory Science|June 25, 2026
Quantifying the Financial Return on Investment of Risk-Based Quality Management Implementation in Clinical DevelopmentAbigail Dirks, Sylviane de Viron, Kenneth McFarlane, et al.
Therapeutic Innovation & Regulatory Science|February 9, 2024
Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical TrialsSylviane de Viron, Laura Trotta, William Steijn, et al.
Therapeutic Innovation & Regulatory Science|October 21, 2022
Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator OutcomesSylviane de Viron, Laura Trotta, William Steijn, et al.
Journal of Medical Internet Research|September 11, 2013
Communicating genetics and smoking through social media: are we there yet?Sylviane de Viron, L Suzanne Suggs, Angela Brand, et al.
BMC Medical Genetics|July 26, 2014
Genetic similarities between tobacco use disorder and related comorbidities: an exploratory studySylviane de Viron, Servaas A Morré, Herman Van Oyen, et al.
Plos One|July 19, 2012
Impact of genetic notification on smoking cessation: systematic review and pooled-analysisSylviane de Viron, Johan Van der Heyden, Elena Ambrosino, et al.
Therapeutic Innovation & Regulatory Science|September 30, 2021
Detection of Fraud in a Clinical Trial Using Unsupervised Statistical MonitoringSylviane de Viron, Laura Trotta, Helmut Schumacher, et al.
Pageof 1